PiCCA Study (Panitumumab in Combination With Cisplatin/Gemcitabine)

NCT01320254 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

93

Enrollment

OTHER

Sponsor class

Conditions

Cholangiocarcinomas

Interventions

DRUG: Cisplatin, Gemcitabine, Panitumumab
DRUG: Cisplatin, Gemcitabine

Sponsor

Hannover Medical School